Epidemiology of Burkholderia Cepacia Infection in Patients with Cystic Fibrosis: Analysis by Randomly Amplified Polymorphic DNA Fingerprinting

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1996 Dec 1

PMID 8940422

Citations 61

Authors

E Mahenthiralingam

M E CAMPBELL

D A Henry

D P Speert

Affiliations

Soon will be listed here.

Abstract

We fingerprinted a collection of 627 Burkholderia cepacia isolates from 255 patients with cystic fibrosis (CF) and 43 patients without CF and from the environment, by a PCR-based randomly amplified polymorphic DNA (RAPD) method with primers selected for their ability to produce discriminatory polymorphisms. The RAPD typing method was found to be reproducible and discriminatory, more sensitive than PCR ribotyping, and able to group epidemiologically related B. cepacia strains previously typed by both pulsed-field gel electrophoresis and conventional ribotyping. Seven strain types infecting multiple CF patients were found at several different CF treatment centers in Canada, the United States, the United Kingdom, France, and Australia, indicating the presence of epidemic strain types. Most CF patients were each colonized with a single strain type, and several patients harbored the same strain type for 5 or more years. B. cepacia isolates recovered from other clinical sources (44 isolates examined) and from the environment (58 isolates examined) possessed RAPD fingerprints that were generally distinct from CF-associated strain types (525 isolates examined). RAPD is a versatile fingerprinting method for studying the epidemiology of B. cepacia.

Citing Articles

A flagella-dependent jumbo phage controls rice seedling rot and steers toward reduced virulence in rice seedlings.

Supina B, McCutcheon J, Peskett S, Stothard P, Dennis J mBio. 2025; 16(3):e0281424.

PMID: 39868782 PMC: 11898562. DOI: 10.1128/mbio.02814-24.

Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen .

Parfitt K, Green A, Connor T, Neill D, Mahenthiralingam E Microbiology (Reading). 2023; 169(8).

PMID: 37526960 PMC: 10482378. DOI: 10.1099/mic.0.001366.

Bacterial Resistance to Antibiotics and Clonal Spread in COVID-19-Positive Patients on a Tertiary Hospital Intensive Care Unit, Czech Republic.

Doubravska L, Htoutou Sedlakova M, Fiserova K, Pudova V, Urbanek K, Petrzelova J Antibiotics (Basel). 2022; 11(6).

PMID: 35740188 PMC: 9219711. DOI: 10.3390/antibiotics11060783.

The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1.

Davis C, Ruest M, Cole J, Dennis J Viruses. 2022; 14(5).

PMID: 35632679 PMC: 9144972. DOI: 10.3390/v14050938.

Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.

Jaiyesimi O, McAvoy A, Fogg D, Garg N Sci Rep. 2021; 11(1):21419.

PMID: 34725378 PMC: 8560942. DOI: 10.1038/s41598-021-00421-4.

References

di SantAgnese P, DAVIS P . Research in cystic fibrosis (third of three parts). N Engl J Med. 1976; 295(11):597-602. DOI: 10.1056/NEJM197609092951105. View

Mahenthiralingam E, CAMPBELL M, Foster J, Lam J, Speert D . Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol. 1996; 34(5):1129-35. PMC: 228968. DOI: 10.1128/jcm.34.5.1129-1135.1996. View

Tablan O, Chorba T, Schidlow D, White J, Hardy K, Gilligan P . Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985; 107(3):382-7. DOI: 10.1016/s0022-3476(85)80511-4. View

Prince A . Antibiotic resistance of Pseudomonas species. J Pediatr. 1986; 108(5 Pt 2):830-4. DOI: 10.1016/s0022-3476(86)80753-3. View

Stull T, LiPuma J, Edlind T . A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis. 1988; 157(2):280-6. DOI: 10.1093/infdis/157.2.280. View

LiPuma J, Mortensen J, Dasen S, Edlind T, Schidlow D, Burns J . Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr. 1988; 113(5):859-62. DOI: 10.1016/s0022-3476(88)80018-0. View

Rabkin C, Jarvis W, Anderson R, GOVAN J, Klinger J, Lipuma J . Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis. 1989; 11(4):600-7. DOI: 10.1093/clinids/11.4.600. View

LiPuma J, Dasen S, Nielson D, Stern R, Stull T . Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990; 336(8723):1094-6. DOI: 10.1016/0140-6736(90)92571-x. View

LiPuma J, Fisher M, Dasen S, Mortensen J, Stull T . Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis. 1991; 164(1):133-6. DOI: 10.1093/infdis/164.1.133. View

10.

Kostman J, Edlind T, LiPuma J, Stull T . Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol. 1992; 30(8):2084-7. PMC: 265447. DOI: 10.1128/jcm.30.8.2084-2087.1992. View

11.

Akopyanz N, Bukanov N, Westblom T, Kresovich S, Berg D . DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992; 20(19):5137-42. PMC: 334296. DOI: 10.1093/nar/20.19.5137. View

12.

Larsen G, Stull T, Burns J . Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol. 1993; 31(4):788-92. PMC: 263564. DOI: 10.1128/jcm.31.4.788-792.1993. View

13.

Govan J, Brown P, Maddison J, Doherty C, Nelson J, Dodd M . Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993; 342(8862):15-9. DOI: 10.1016/0140-6736(93)91881-l. View

14.

Bingen E, Weber M, Derelle J, Brahimi N, Vidailhet M, Navarro J . Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol. 1993; 31(10):2589-93. PMC: 265941. DOI: 10.1128/jcm.31.10.2589-2593.1993. View

15.

Smith D, Gumery L, Smith E, Stableforth D, Kaufmann M, Pitt T . Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol. 1993; 31(11):3017-22. PMC: 266193. DOI: 10.1128/jcm.31.11.3017-3022.1993. View

16.

Pegues D, Carson L, Tablan O, FitzSimmons S, Roman S, Miller J . Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr. 1994; 124(5 Pt 1):694-702. DOI: 10.1016/s0022-3476(05)81357-5. View

17.

Johnson W, Tyler S, ROZEE K . Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol. 1994; 32(4):924-30. PMC: 263164. DOI: 10.1128/jcm.32.4.924-930.1994. View

18.

Steinbach S, Sun L, Jiang R, Flume P, Gilligan P, Egan T . Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994; 331(15):981-7. DOI: 10.1056/NEJM199410133311504. View

19.

Mahenthiralingam E, Campbell M, Speert D . Burkholderia cepacia in cystic fibrosis. N Engl J Med. 1995; 332(12):819. DOI: 10.1056/NEJM199503233321213. View

20.

Govan J . Burkholderia cepacia in cystic fibrosis. N Engl J Med. 1995; 332(12):819-20; author reply 820-1. View